This would aid the volume of plasma collected per center, but also reduce blood donor screening. We also think CSL benefits from superior fractionation expertise and quality processes, enabling ...
Pharmaceuticals company CSL on Tuesday reported a 3% rise in first-half profit, benefiting from further growth in its main blood-plasma business.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback